Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Xunyuan Mao"'
Autor:
Yan Zhang, Jiayan Gao, Yan He, Ziwei Qi, Long Qian, Wanpei Chen, Haiyan Xu, Yanhua Yue, Xunyuan Mao, Shuxin Guo, Yan Zhou, Shuru Zhou, Songbing Qin, Xueguang Zhang, Yuhui Huang
Publikováno v:
Journal of Immunology Research, Vol 2023 (2023)
Anti-PD-L1 therapy exhibits durable efficacy, but only in a small fraction of cancer patients. The immunosuppressive tumor microenvironment (TME) is a crucial obstacle that impedes cancer immunotherapy. Here, we found that anti-PD-L1 therapy coupled
Externí odkaz:
https://doaj.org/article/ac5d98fa4c124389a69fad2d6c6c1464
Autor:
Yanhua Yue, Yang Cao, Xunyuan Mao, Fei Wang, Peng Fan, Long Qian, Shuxin Guo, Feng Li, Yanting Guo, Tongbing Chen, Yan Lin, Weimin Dong, Yue Liu, Yuhui Huang, Weiying Gu
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
Multiple myeloma (MM) remains a common hematologic malignancy with a 10-year survival rate below 50%, which is largely due to disease relapse and resistance. The lack of a simple and practical approach to establish myeloma patient-derived xenograft (
Externí odkaz:
https://doaj.org/article/76a9c38f58c44d7792c0b79bd02f7a9c
Autor:
Yanhua Yue, Yang Cao, Fei Wang, Naidong Zhang, Ziwei Qi, Xunyuan Mao, Shuxin Guo, Feng Li, Yanting Guo, Yan Lin, Weimin Dong, Yuhui Huang, Weiying Gu
Publikováno v:
Leukemia Research. 128:107068
Autor:
Yanhua, Yue, Yang, Cao, Fei, Wang, Naidong, Zhang, Ziwei, Qi, Xunyuan, Mao, Shuxin, Guo, Feng, Li, Yanting, Guo, Yan, Lin, Weimin, Dong, Yuhui, Huang, Weiying, Gu
Publikováno v:
Leukemia Research. 122:106949
Multiple myeloma (MM) remains an incurable hematologic malignancy due to its frequent drug resistance and relapse. Cluster of Differentiation 47 (CD47) is reported to be highly expressed on MM cells, suggesting that the blockade of CD47 signaling pat